1. Home
  2. FTLF vs RLYB Comparison

FTLF vs RLYB Comparison

Compare FTLF & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

HOLD

Current Price

$9.25

Market Cap

86.6M

Sector

Health Care

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

N/A

Current Price

$16.93

Market Cap

89.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTLF
RLYB
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.6M
89.2M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
FTLF
RLYB
Price
$9.25
$16.93
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$21.50
N/A
AVG Volume (30 Days)
11.9K
7.3K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
6.16
Revenue
$21,744,000.00
$858,000.00
Revenue This Year
$45.76
N/A
Revenue Next Year
$5.10
N/A
P/E Ratio
$25.08
$2.75
Revenue Growth
11.52
43.00
52 Week Low
$8.67
$0.48
52 Week High
$20.98
$17.57

Technical Indicators

Market Signals
Indicator
FTLF
RLYB
Relative Strength Index (RSI) 40.42 49.87
Support Level $8.88 $16.51
Resistance Level $9.87 $17.32
Average True Range (ATR) 0.35 0.41
MACD -0.02 -0.01
Stochastic Oscillator 12.41 41.98

Price Performance

Historical Comparison
FTLF
RLYB

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: